This site is now managed by the Commonwealth Department of Health and Aged Care. 

Australian Clinical Trials

Clinical Trial Details

A Pilot Study Exploring the potential benefits of Nursing Case Management In the Management of older Patients with Myeloma

Print record Print record
Trial Information

Broad Health Condition Cancer

Specific Health ConditionMyeloma

Trial FocusEducational / counselling / training

Recruitment Details

Recruitment status

Recruitment State


Anticipated date of last participant enrolment28/12/2023

Phase of TrialNot Applicable

Has the study received ethics approval?Further information iconApproved

Trial summary

This study is investigating the perceived benefit of implementing a nurse led model of care for older myeloma patients undergoing oral cancer treatment.
Who is it for?
You may be eligible for this study if you are aged 65 years or older, you are newly diagnosed with Myeloma or first relapse and are being treated at one of the participating hospitals in South Australia.

Study details
All enrolled participants will be provided with additional education about the disease and treatment by a specialist nurse.  The specialist nurse will also act as a first point of contact during chemotherapy to answer questions and provide additional support to participants as required.  Participants will have their medical records reviewed by the specialist nurse and may be asked to complete questionnaires at various timepoints over a 12 month period.

It is hoped this research will demonstrate that a nurse led model of care for older patients with myeloma has a positive impact on their treatment completion rates and quality of life during cancer treatment.


Key inclusion criteria

•	Diagnosis of Myeloma according to the WHO (2008) classification, aged 65years and over 
•	MGUS patients progressed to Myeloma needing treatment
•	Relapsed Myeloma patients needing treatment
•	Capacity to understand and voluntarily sign an informed consent form
•	Able to be followed at the Royal Adelaide Hospital/The Queen Elizabeth Hospital

Minimum age65 Years

GenderBoth males and females

Can Healthy volunteers participate? No

Key exclusion criteria

•	Primary Haematologist does not practice at the Royal Adelaide Hospital/ The Queen Elizabeth Hospital
•	patients <65 years of age
•	Any significant condition that would confound the collection or interpretation of data from the study
Contact details and further information

Sponsor Primary Sponsor Type: Commercial sector/Industry
Primary Sponsor Name: BMS-celgene
Primary Sponsor Address: Level 2/4 Nexus Court Mulgrave VIC 3170 Australia
Primary Sponsor Country: Australia

Trial IDACTRN12621000261819

Contact person for information and recruitmentDr
Cindy Lee
Royal Adelaide Hospital Haematology Port Rd Adelaide SA 5000
+61 8 7074 2356

Email contact Further information